Arcellx’s stock is heading toward a record after the $7.8 billion deal to be acquired by Gilead.
Source link
#Gilead #shows #belief #partners #cancer #treatment #billion #buyout
Trending
- After ‘slogger’ remark, Pakistan’s Mohammad Amir makes fresh Abhishek Sharma admission: ‘India were exposed’ | Cricket News – The Times of India
- Fortune Brands stock faces investor push to replace incoming CEO
- Watch: FBI Director Kash Patel drinks beer with Team USA ice hockey team, social media says he recreates Drake meme – The Times of India
- Tejas incident: Minor glitch, not a crash, says HAL | India News – The Times of India
- Before Joker, Joaquin Phoenix Briefly Played A DC Superhero In A Forgotten TV Show – SlashFilm
- Baftas 2026: BBC apologises after guest with Tourette’s shouts racial slur at Delroy Lindo and Michael B Jordan
- Stop using a controller to play Fortnite Festival — the guitar-shaped PDP Riffmaster is down to its best price in almost a year
- TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update
Gilead shows its belief in its partner’s cancer treatment with a $7.8 billion buyout
By V. Alure
